Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Palliative Care to Improve Quality of Life in CHF and COPD


Collapse Biography 

Collapse Overview 
Collapse abstract
? DESCRIPTION (provided by applicant): Chronic heart failure (CHF) and chronic obstructive pulmonary disease (COPD) together affect up to 25% of Veterans. Despite disease-specific medical care for CHF and COPD, Veterans with either illness are often left with poor quality of life (i.e., burdensome symptoms, impaired function). Quality of life is reduced for similar reasons in both illnesses, particularly from the burden of significant residual symptoms such as shortness of breath and fatigue and other concurrent symptoms such as pain and depression. Furthermore, while CHF and COPD are leading causes of hospitalization and mortality, few Veterans with either illness engage in advance care planning, the process of considering and communicating healthcare values and goals. While palliative care is often thought of only at the end of life, it has great potential t improve quality of life and advance care planning for Veterans earlier in illness, concomitant with ongoing medical management. Our preliminary studies demonstrate early success with a Veteran-centered palliative care intervention in CHF and COPD. The palliative care intervention, Collaborative care to Alleviate Symptoms and Adjust to illness (CASA) consists of the following components: (1) algorithm-guided management of breathlessness, fatigue, and pain, provided by a nurse; the algorithms supplement disease-focused treatments with palliative and behavioral treatments; (2) a 6-session psychosocial care program targeting adjustment to illness and depression, provided by a social worker; and (3) engagement of patients and providers in advance care planning. We propose conducting a hybrid effectiveness and implementation study to further evaluate the CASA intervention. Population-based sampling methods will be used to enroll 300 Veterans with CHF or COPD who have poor quality of life and are at risk for hospitalization or death. The primary aim is to test the effectiveness of CASA in a randomized controlled trial (intervention vs. enhanced usual care) in two VA health care systems. We will determine the effect of the CASA intervention on (a) quality of life as a primary outcome, and (b) disease-specific health status, depression, symptom burden, advance care planning communication and documentation, emergency department visits, hospitalizations, and mortality as secondary outcomes. In a secondary aim in this study, we will use a combination of qualitative and quantitative methods to examine the implementation of the intervention. Information on implementation is rarely collected systematically in effectiveness studies, even though it is critical to guide the development of future interventions and for successful implementation and dissemination of palliative care and team-based interventions. The information gained from this aim will inform future palliative care and team-based interventions as well as ways to expand the reach of palliative care. The proposed study is significant because it aims to improve quality of life and provision of care according to Veterans' goals and preferences in common, burdensome illnesses. The study is innovative because it (1) tests the effectiveness of palliative care in CHF and COPD, leading causes of death among Veterans; (2) combines palliative and disease-specific care for symptoms with psychosocial treatment for depression to improve quality of life; and (3) leverages the skills of affiliate health providers (nurses, social workers) to provide basic palliative care, with physician supervision; and (4) uses an hybrid effectiveness/implementation design to increase the relevance to operations leaders and future research. The research team has expertise in behavioral and health care delivery clinical trials, CHF and COPD, and implementation science.
Collapse sponsor award id
I01HX001770

Collapse Time 
Collapse start date
2016-07-01
Collapse end date
2020-12-31

Copyright © 2021 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)